Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. SMD Rise PCL's annualizedNet Income for the quarter that ended in Mar. 2026 was ฿-122.2 Mil. SMD Rise PCL's average total tangible assets for the quarter that ended in Mar. 2026 was ฿1,388.7 Mil. Therefore, SMD Rise PCL's annualized Return-on-Tangible-Asset for the quarter that ended in Mar. 2026 was -8.80%.
The historical rank and industry rank for SMD Rise PCL's Return-on-Tangible-Asset or its related term are showing as below:
BKK:SMD100-R'
s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: 0.5 Med: 13.08 Max: 31.72
Current: 0.5
During the past 8 years, SMD Rise PCL's highest Return-on-Tangible-Asset was 31.72%. The lowest was 0.50%. And the median was 13.08%.
BKK:SMD100-R's Return-on-Tangible-Asset is ranked worse than 71.19% of 118
companies
in the Medical Distribution industry
Industry Median: 2.305
vs BKK:SMD100-R: 0.50
Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.
Be Aware
Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the companys earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a companys tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.
SMD Rise PCL Return-on-Tangible-Asset Related Terms
SMD Rise PCL Return-on-Tangible-Asset Historical Data
* Premium members only.
The historical data trend for SMD Rise PCL's Return-on-Tangible-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BKK:SMD100-R vs MCK, CAH, COR: Return-on-Tangible-Asset Comparison
For the Medical Distribution subindustry, SMD Rise PCL's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
SMD Rise PCL Return-on-Tangible-Asset vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, SMD Rise PCL's Return-on-Tangible-Asset distribution charts can be found below:
* The bar in red indicates where SMD Rise PCL's Return-on-Tangible-Asset falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is four times the quarterly (Mar. 2026) net income data.
What does a Return-on-Tangible-Asset of -8.80% mean?
SMD Rise PCL (BKK:SMD100-R) has a Return-on-Tangible-Asset of -8.80% as of Mar. 2026. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on SMD Rise PCL and its competitors. Over the past decade, SMD Rise PCL's Return-on-Tangible-Asset has ranged from 0.50 to 31.72. According to the industry distribution chart, SMD Rise PCL ranks #84 out of 118 companies in the Medical Distribution industry, placing it in the top 71.2%.
Is SMD Rise PCL's Return-on-Tangible-Asset too high?
SMD Rise PCL's current Return-on-Tangible-Asset is -8.80%. Over the past 10 years, this metric has ranged from a low of 0.50 to a high of 31.72. Based on the distribution chart, SMD Rise PCL ranks #84 out of 118 companies in the Medical Distribution industry, which is below the industry midpoint. Overall, SMD Rise PCL has a GF Score™ of 59/100, reflecting its overall financial health beyond just this single metric.
How does SMD Rise PCL's Return-on-Tangible-Asset compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, SMD Rise PCL ranks #84 out of 118 companies for Return-on-Tangible-Asset. This places SMD Rise PCL in the lower half of its industry. The industry median Return-on-Tangible-Asset is 2.31. Historically, SMD Rise PCL's own Return-on-Tangible-Asset has ranged from 0.50 to 31.72 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Asset for a Medical Distribution company?
The median Return-on-Tangible-Asset among Medical Distribution companies is 2.31, based on 118 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Asset significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Asset mean?
A high Return-on-Tangible-Asset can signal that a stock is expensive relative to its fundamentals. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on SMD Rise PCL and its competitors. For the Medical Distribution industry, the median Return-on-Tangible-Asset is 2.31 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. SMD Rise PCL's current Return-on-Tangible-Asset is -8.80%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SMD Rise PCL stock overvalued right now?
SMD Rise PCL (BKK:SMD100-R) has a current Return-on-Tangible-Asset of -8.80%. The stock's GF Value™ is ฿24.66, compared to a current price of ฿5.85 — trading 76.3% below its estimated fair value. The current Return-on-Tangible-Asset is -8.80%. SMD Rise PCL's overall GF Score™ is 59/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Asset calculated?
Return-on-Tangible-Asset is calculated from a company's financial statements. For SMD Rise PCL (BKK:SMD100-R), the current Return-on-Tangible-Asset is -8.80% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is SMD Rise PCL (BKK:SMD100-R) Overvalued in 2026?
Based on GuruFocus' analysis, SMD Rise PCL stock appears to be undervalued.
The current stock price of ฿5.85 is trading 76.3% below its estimated GF Value™ of ฿24.66.
Key valuation signals for BKK:SMD100-R:
Return-on-Tangible-Asset: -8.80%
GF Value™: ฿24.66 vs. price of ฿5.85 (76.3% below fair value)
No single metric tells the full story. See the BKK:SMD100-R stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Address222,222/1-2 Moo 1, Rattanathibet Road, West Inn Complex Building, 10th Floor, Bang Rak Yai Subdistrict, Bang Bua Thong District, Nonthaburi Province, Bangkok, THA, 11110
SMD Rise PCL, formerly Saintmed PCL is engaged in the import and distribution of medical devices and equipment, rental services for medical equipment, and providing services related to medical equipment. It operates in Thailand. The Group is engaged in three operating segments: Sale of medical devices and equipment, medical supplies, Services of medical equipment at sleep lab centers and repair services, and Revenue from rental of medical equipment at wellness centers and other services. The Group is managed and operates principally in Thailand.
59GF Score
Get the complete analysis for BKK:SMD100-R
Return-on-Tangible-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:SMD100-R has been successfully added to your 
